文献速递脑血管病

直接口服抗凝药相关脑出血与维生素K拮抗剂相关脑出血的比较

Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage.
PubMed 文献 · Neurology · 2017-08-16

本研究前瞻性纳入161例非瓣膜性房颤患者抗凝相关自发性脑出血,比较DOAC与VKA相关脑出血的神经影像和临床结局,并荟萃分析观察性研究。发现DOAC相关脑出血基线血肿体积更小、神经功能缺损更轻、严重脑出血比例更低。

要点

  • DOAC相关脑出血患者入院时NIHSS评分和血肿体积均低于VKA相关脑出血。
  • DOAC相关脑出血严重ICH(>2分)比例更低(17.0% vs 36.8%)。
  • 荟萃分析显示DOAC相关脑出血与更低的院内死亡率相关(OR 0.44)。

核心结论

  • 与VKA相关脑出血相比,DOAC相关脑出血与更小的基线血肿体积和入院时更轻的神经功能缺损相关。

研究设计与样本

  • 前瞻性队列研究纳入13个三级卒中中心12个月内连续收治的161例非瓣膜性房颤抗凝相关自发性脑出血患者(平均年龄75.6±9.8岁,57.8%男性)。
  • 同时系统检索并荟萃分析符合条件的观察性研究,报告VKA或DOAC相关脑出血的基线特征和结局。

主要发现

  • DOAC相关脑出血(n=47)与VKA相关脑出血(n=114)在人口学、血管危险因素、HAS-BLED和CHA2DS2-VASc评分及抗血小板治疗前等方面无差异,但VKA相关脑出血慢性肾脏病患病率更高。
  • DOAC相关脑出血中位NIHSSadm评分更低(8[3-14] vs 15[7-25],p=0.003),中位基线血肿体积更小(12.8[4-40] vs 24.3[11-58.8] cm3,p=0.007),中位ICH评分更低(1[0-2] vs 2[1-3],p=0.049)。
  • 严重ICH(>2分)在DOAC相关脑出血中更少见(17.0% vs 36.8%,p=0.013)。
  • 多变量分析中,DOAC相关脑出血独立关联更低的基线血肿体积(p=0.006)、更低的NIHSSadm评分(p=0.022)和更低的重度ICH可能性(OR 0.34,95%CI 0.13-0.87,p=0.025)。
  • 荟萃分析中,DOAC相关脑出血与入院CT更低基线血肿体积相关(标准化均数差=-0.57,95%CI -1.02至-0.12,p=0.010)和更低院内死亡率相关(OR=0.44,95%CI 0.21-0.91,p=0.030)。

临床怎么用

  • 对于非瓣膜性房颤患者,DOAC相关脑出血可能表现为更小的血肿和更轻的神经功能缺损,临床评估时应考虑抗凝药物类型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the neuroimaging profile and clinical outcomes among patients with intracerebral hemorrhage (ICH) related to use of vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) for nonvalvular atrial fibrillation (NVAF). METHODS: We evaluated consecutive patients with NVAF with nontraumatic, anticoagulant-related ICH admitted at 13 tertiary stroke care centers over a 12-month period. We also performed a systematic review and meta-analysis of eligible observational studies reporting baseline characteristics and outcomes among patients with VKA- or DOAC-related ICH. RESULTS: We prospectively evaluated 161 patients with anticoagulation-related ICH (mean age 75.6 ± 9.8 years, 57.8% men, median admission NIH Stroke Scale [NIHSSadm] score 13 points, interquartile range 6-21). DOAC-related (n = 47) and VKA-related (n = 114) ICH did not differ in demographics, vascular risk factors, HAS-BLED and CHA2DS2-VASc scores, and antiplatelet pretreatment except for a higher prevalence of chronic kidney disease in VKA-related ICH. Patients with DOAC-related ICH had lower median NIHSSadm scores (8 [3-14] vs 15 [7-25] points, p = 0.003), median baseline hematoma volume (12.8 [4-40] vs 24.3 [11-58.8] cm3, p = 0.007), and median ICH score (1 [0-2] vs 2 [1-3] points, p = 0.049). Severe ICH (>2 points) was less prevalent in DOAC-related ICH (17.0% vs 36.8%, p = 0.013). In multivariable analyses, DOAC-related ICH was independently associated with lower baseline hematoma volume (p = 0.006), lower NIHSSadm scores (p = 0.022), and lower likelihood of severe ICH (odds ratio [OR] 0.34, 95% confidence interval [CI] 0.13-0.87, p = 0.025). In meta-analysis of eligible studies, DOAC-related ICH was associated with lower baseline hematoma volumes on admission CT (standardized mean difference = -0.57, 95% CI -1.02 to -0.12, p = 0.010) and lower in-hospital mortality rates (OR = 0.44, 95% CI 0.21-0.91, p = 0.030). CONCLUSIONS: DOAC-related ICH is associated with smaller baseline hematoma volume and lesser neurologic deficit at hospital admission compared to VKA-related ICH.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Tsivgoulis G, Lioutas VA, Varelas P, et al. Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage. Neurology. 2017. PMID: 28814457. doi:10.1212/WNL.0000000000004362

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。